| FYMOBRI CLEMENTIA PHARMACEUTICALS INC.
2199304 20 Jul 2022 | on 11 Jan 2023 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations. | | | FYGOFRI TAIHO PHARMACEUTICAL CO. LTD.
2143365 31 Aug 2021 | on 03 May 2024 | Class 005 Class 005 Pharmaceutical Products Anti-cancer preparations; anti-cancer agents; anti-tumor agents; diagnostic reagents for medical purposes in the field of oncology; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for treating malignant tumors. | | | FYTIMRI BRISTOL-MYERS SQUIBB COMPANY
(A DELAWARE CORPORATION)
1657171 19 Dec 2013 | on 10 Jan 2018 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, respiratory diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use relating to metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents. | | 
